However, caution is required when using HDACis because in addition to a suppression of lymph node tumor growth, pharmacological inhibition of HDAC11 enhances metastasis from the lymph node to distant sites (Leslie et al., 2019). This evidence concerns the gene HDAC11 and lymph node neoplasm.